Clinical Trial Update: Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression [Phase 3]

View source ↗

Summary

Phase IIIb study assessing the effectiveness and safety of Atazanavir/ritonavir as a single boosted protease inhibitor therapy in HIV-infected subjects with vir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Human Immunodeficiency Virus (HIV) Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-07-19